Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle
- PMID: 1738192
- PMCID: PMC240853
- DOI: 10.1128/JVI.66.3.1321-1328.1992
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle
Abstract
In this study, we have analyzed the effect of human alpha interferon (IFN-alpha) on a single replication cycle of human immunodeficiency virus type 1 (HIV-1) infection in the lymphocytic cell line CEM-174, which is highly sensitive to the antiviral effects of IFN. Pretreatment of cells with 50 to 500 U of recombinant human IFN-alpha per ml resulted in a marked reduction in viral RNA and protein synthesis. The effect of IFN-alpha was dose dependent and was amplified in multiple infection cycles. IFN-induced inhibition of viral protein synthesis could be detected only when cells were treated with IFN-alpha prior to infection or when IFN-alpha was added up to 10 h postinfection, but not if IFN-alpha was added at the later stages of HIV-1 replication cycle or after the HIV-1 infection was already established. Analysis of the integrated HIV-1 provirus showed a marked decrease in the levels of proviral DNA in IFN-treated cells. Thus, in contrast to the previous studies on established HIV-1 infection in T cells, in which the IFN block appeared to be at the posttranslational level, during de novo infection, IFN-alpha interferes with an early step of HIV-1 replication cycle that occurs prior to the integration of the proviral DNA. These results indicate that the early IFN block of HIV-1 replication, which has been previously observed only in primary marcophages, can also be detected in the IFN-sensitive T cells, indicating that the early IFN block is not limited to macrophages.
Similar articles
-
Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.Virology. 1993 Mar;193(1):303-12. doi: 10.1006/viro.1993.1126. Virology. 1993. PMID: 8438572
-
Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.Virology. 1998 Aug 1;247(2):265-73. doi: 10.1006/viro.1998.9249. Virology. 1998. PMID: 9705919
-
[Anti-HIV effects of IFN-tau in human macrophages: role of cellular antiviral factors and interleukin-6].Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):492-503. doi: 10.1016/j.patbio.2008.06.002. Epub 2008 Oct 7. Pathol Biol (Paris). 2008. PMID: 18842358 French.
-
Multiple effects of interferon on HIV-1 replication.J Interferon Res. 1991 Dec;11(6):313-8. doi: 10.1089/jir.1991.11.313. J Interferon Res. 1991. PMID: 1686880 Review. No abstract available.
-
Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus.Pathobiology. 1991;59(4):209-13. doi: 10.1159/000163647. Pathobiology. 1991. PMID: 1883515 Review.
Cited by
-
Productive expression state confers resistance of human immunodeficiency virus (HIV)-2-infected lymphoma cells against superinfection by HIV-1.Arch Virol. 1993;131(3-4):419-29. doi: 10.1007/BF01378642. Arch Virol. 1993. PMID: 8347081
-
The IFITM proteins inhibit HIV-1 infection.J Virol. 2011 Mar;85(5):2126-37. doi: 10.1128/JVI.01531-10. Epub 2010 Dec 22. J Virol. 2011. PMID: 21177806 Free PMC article.
-
Minimally Modified HIV-1 Infection of Macaques: Development, Utility, and Limitations of Current Models.Viruses. 2024 Oct 16;16(10):1618. doi: 10.3390/v16101618. Viruses. 2024. PMID: 39459950 Free PMC article. Review.
-
Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry.J Virol. 1999 Sep;73(9):7891-8. doi: 10.1128/JVI.73.9.7891-7898.1999. J Virol. 1999. PMID: 10438887 Free PMC article.
-
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.J Infect Dis. 2010 Jun 1;201(11):1686-96. doi: 10.1086/652420. J Infect Dis. 2010. PMID: 20420510 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources